Recro Pharma (REPH) Earnings
|
Expand Research on REPH
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -249.5% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -14.1% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/9/20 |  |
Q320 | -$0.09 | -$0.20 | +$0.11 | $19.29M | $16.33M | = |  | | Details |
| 8/10/20 | |
Q220 | -$0.26 | -$0.16 | -$0.10 | $15.52M | $18.88M | = | | | Details |
| 5/11/20 | |
Q120 | -$0.33 | -$0.03 | -$0.30 | $21.78M | $19.45M | = | | | Details |
3/4/20  |
|
Q419 | N/A | -$0.25 | N/A | N/A | $19.55M | = | N/A | N/A | |
| 11/8/19 | |
Q319 | -$0.19 | -$0.21 | +$0.02 | $25.3M | $20.35M | = | | | Details |
| 8/8/19 | |
Q219 | -$0.13 | -$0.42 | +$0.29 | $31.26M | $23.59M | = | | | Details |
| 5/10/19 | |
Q119 | -$0.10 | -$1.06 | +$0.96 | $25.07M | $20.51M | = | | | Details |
| 2/19/19 | |
Q418 | -$0.58 | -$0.75 | +$0.17 | $17.78M | $16.05M | = | | | Details |
